机构:[1]Department ofOphthalmology, McGillUniversity, Montreal, Quebec,Canada[2]Genentech, Inc, SouthSan Francisco, California, USA[3]Beijing Tongren Eye Center,Beijing, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[4]Jacobs Retina Center at ShileyEye Center, University ofCalifornia, San Diego, La Jolla,California, USA[5]Smt. Kanuri SanthammaRetina Vitreous Centre, L.V.Prasad Eye Institute,Hyderabad, Telangana, India[6]VST Glaucoma Center, L.V.Prasad Eye Institute,Hyderabad, Telangana, India[7]Narayana Netralaya,Bangalore, Karnataka, India
Purpose To analyse the topographic changes in retinal ganglion cells (RGCs) in eyes with unilateral naive branch retinal vein occlusion (BRVO) in comparison to normal fellow eyes and to healthy control eyes. Methods We performed a retrospective analysis of 66 eyes (33 subjects) with naive unilateral BRVO who underwent spectral-domain optical coherence tomography using Cirrus HD-OCT. We also included 67 eyes of 48 age-matched healthy volunteers as control group. Average, minimum and sectoral macular ganglion cell-inner plexiform layer (GCIPL) thickness, macular retinal nerve fibre layer (RNFL) thickness and outer retinal thickness were collected. Comparison of the GCIPL, RNFL and outer retinal thicknesses among study eyes, normal fellow eyes and control groups was performed. Results The average and minimum macular GCIPL thicknesses were constantly and diffusely reduced in BRVO compared with normal fellow eyes and healthy controls (p<0.001 for each GCIPL sector). The average macular RNFL thickness was reduced in BRVO eyes compared with normal fellow eyes (p=0.01) and tended to be lower than controls (p=0.07). The minimum RNFL thickness in eyes with BRVO was significantly reduced when compared with fellow eyes (p<0.001) and control eyes (p<0.001). The average outer retina thickness was thicker in BRVO eyes compared with both fellow eyes (p<0.001) and controls (p<0.001). Conclusions A significant reduction of the macular GCIPL and RNFL thicknesses was observed in eyes with BRVO. This finding is suggestive of RGCs degeneration; the neuroprotective effect of current therapeutic options might be an important consideration when evaluating treatment strategies and prognosticating visual outcome in BRVO eyes.
通讯机构:[5]Smt. Kanuri SanthammaRetina Vitreous Centre, L.V.Prasad Eye Institute,Hyderabad, Telangana, India[*1]Smt. Kanuri Santhamma Centre for VitreoRetinal Diseases, L.V. Prasad Eye Institute, L.V. Prasad Marg, Banjara Hills, Hyderabad 500 034, Telangana, India
推荐引用方式(GB/T 7714):
Alshareef Rayan A.,Barteselli Giulio,You Qisheng,et al.In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion[J].BRITISH JOURNAL OF OPHTHALMOLOGY.2016,100(11):1506-1510.doi:10.1136/bjophthalmol-2015-308106.
APA:
Alshareef, Rayan A.,Barteselli, Giulio,You, Qisheng,Goud, Abhilash,Jabeen, Asiya...&Chhablani, Jay.(2016).In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion.BRITISH JOURNAL OF OPHTHALMOLOGY,100,(11)
MLA:
Alshareef, Rayan A.,et al."In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion".BRITISH JOURNAL OF OPHTHALMOLOGY 100..11(2016):1506-1510